Lessons from the development of new adenosine A2A receptor agonists
- PMID: 19356443
- DOI: 10.1016/j.jcmg.2008.03.003
Lessons from the development of new adenosine A2A receptor agonists
Comment on
-
Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.JACC Cardiovasc Imaging. 2008 May;1(3):307-16. doi: 10.1016/j.jcmg.2008.02.003. JACC Cardiovasc Imaging. 2008. PMID: 19356442 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
